unmet needs in unfit/frail patients with multiple myeloma
Published 3 years ago • 47 plays • Length 4:48Download video MP4
Download video MP3
Similar videos
-
0:51
key unmet needs in the treatment of immune-mediated ttp
-
3:25
unmet needs and unanswered questions in multiple myeloma
-
3:59
addressing the unmet need for patients with lenalidomide-refractory multiple myeloma
-
1:27
unmet needs and future questions in cellular therapy for myeloma
-
1:41
current and emerging unmet needs in r/r multiple myeloma: improving qol & novel therapeutic options
-
1:53
unmet needs in amyloidosis: early diagnosis, treating relapsed disease & progression criteria
-
1:23
unmet clinical needs in multiple myeloma
-
1:03:49
eating pears can affect cancer treatment?!
-
8:14
progress in the treatment of tp53 mutated aml
-
9:25
mgus diagnosis: a step-by-step approach
-
3:10
is there a benefit to rituximab maintenance after first-line bendamustine-rituximab for mcl?
-
4:03
managing unfit/frail mm patients
-
0:51
unmet needs in front-line therapy for patients with flt3-mutated aml
-
2:11
unmet needs in bone marrow failure syndromes & myeloid malignancies: characterization & novel agents
-
2:50
unmet needs in amyloidosis
-
1:06
unmet needs in scd: the need for improved therapies and combination approaches
-
0:45
unmet needs that remain for patients with al amyloidosis who fail frontline treatment
-
1:30
addressing unmet needs in myelofibrosis: alleviating anemia
-
2:44
myeloma qol through induction and maintenance
-
0:51
unmet need in hemophilia a: breakthrough bleeds
-
2:46
managing patients with high-risk myeloma